BridgeBio Oncology Therapeutics (BBOT) Non Operating Investment Income (2024 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted Non Operating Investment Income of -$140000.0 for Q2 2025, up 10.83% sequentially from -$157000.0 in Q1 2025, and down 137.29% YoY from $375454.5 in Q2 2024.
Powered by 
Analysis
BridgeBio Oncology Therapeutics (BBOT) Non Operating Investment Income (2024 - 2026) Analysis & Trends
BridgeBio Oncology Therapeutics has reported Non Operating Investment Income for 2 years, with the latest figure at -$140000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | BridgeBio Oncology Therapeutics | 721.29 Mn | 495.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -997,000.00 |
| Jun 30, 2025 | -140,000.00 |
| Mar 31, 2025 | -157,000.00 |
| Jun 30, 2024 | -59,000.00 |